Research Institute of the McGill University Health Centre — Montreal, Quebec

Public research footprint of Research Institute of the McGill University Health Centre, compiled from the ClinicalTrials.gov public registry.

109

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Stage III Prostate Adenocarcinoma AJCC v7 · Anatomic Stage IV Breast Cancer American Joint Committee on Cancer… · Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma · Myelodysplastic Syndrome With Excess Blasts-1

Recently updated registry entries

NCT03907488 — Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in… (Active Not Recruiting)
NCT01272037 — Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in… (Active Not Recruiting)
NCT06770582 — Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Research Institute of the McGill University Health Centre?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.